Spyre Therapeutics Inc. (SYRE)

Spyre Therapeutics Inc.

SYRE

Super Fund	Position	Shares	Curr. Value	Port. %	Activity
Blackstone	Equity	489,248	$7,894,016	0.03%	+8.92%
Soros Fund Management	Equity	125,000	$2,016,875	0.03%	-50.00%

Total Shares Held: 614,248

Total Value Reported: $9,910,891

Average Allocation per Portfolio 0.03%

Largest Single Portfolio Allocation: 0.03%

Largest Shareholder: Blackstone

Change in Total Shares Held (Q on Q): -84,953

Percentage Change in Shares Held (Q on Q): -12.15%

Number of Current Holders: 2

Number of New Holders (Q on Q): 0

Number of Funds with Additions (Q on Q): 1

Number of Funds with Deductions (Q on Q): 1

Number of Funds Fully Divested (Q on Q): 0

Number of Funds with No Change (Q on Q): 0